Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
October 27, 2015
Patent Application Number
14821585
Date Filed
August 7, 2015
Patent Citations Received
Patent Primary Examiner
Patent abstract
The present invention provides an injectable particle comprising dasatinib acetate and a hyaluronic acid. The hyaluronic acid may be acetylated or sulfated. The particle is for the use of cancer therapy. The injectable particle may further comprises an acid, wherein the acid is dispersed evenly in the matrix of the injectable particle.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
